Jakura 5mg
| SKU | 2689 |
|---|---|
| Generic For | Tofacitinib |
| Manufacturer | Hetero Labs Ltd, India |
| Active Ingredient | Tofacitinib |
| Pack Size | Qty | Price Per Pill or Unit | Price | Cart | |
|---|---|---|---|---|---|
| 60 Tablet/s | US$ 0.62 | US$ 37.5025%US$ 50.00 | |||
|
|||||
| 120 Tablet/s | US$ 0.62 | US$ 75.0025%US$ 100.00 | |||
|
|||||
Jakura 5mg (Tofacitinib)
Jakura 5 mg contains Tofacitinib as the main active compound and is an oral Janus kinase (JAK) inhibitor. Tofacitinib treats several autoimmune conditions. 5 mg is the common dosage for conditions such as:
- Rheumatoid arthritis - It helps reduce inflammation, pain, and joint damage.
- Psoriatic arthritis - It can help alleviate symptoms of joint pain and swelling.
- Ulcerative colitis - Used in cases where other treatments are not effective.
- Atopic dermatitis - It can reduce the symptoms of eczema.
Jakura 5mg helps decrease joint pain and swelling by reducing tenderness and inflammation; it slows down the progression of bone and joint damage. Depending on a patient's health, you may be prescribed Jakura 5mg as a single or combined with other medicines.
How does Jakura 5mg work?
This medicine works as below:
- JAK Inhibition - Tofacitinib is classified as a Janus kinase inhibitor (JAK inhibitor). The JAK family includes four enzymes: JAK1, JAK2, JAK3, and TYK2. These enzymes play a critical role in transmitting signals from cytokine receptors on the surface of cells to the inside of the cell, influencing gene expression and immune cell function.
- Blocking cytokine signaling - Cytokines are signaling molecules that regulate immune responses and inflammation. Many cytokines, such as interleukins (IL-2, IL-6, IL-17) and interferons, use the JAK-STAT (Signal Transducer and Activator of Transcription) pathway to exert their effects. Tofacitinib selectively inhibits JAK1 and JAK3 (to a lesser extent), which are involved in the signaling of several pro-inflammatory cytokines. By blocking JAK enzymes, tofacitinib reduces the activity of immune cells that promote inflammation, including T-cells, B-cells, and macrophages.
Reduction of inflammation - In rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis, the immune system mistakenly attacks the body's own tissues, leading to chronic inflammation. By dampening cytokine signaling, tofacitinib helps reduce the inflammatory response, decreasing symptoms like joint pain, swelling, and gut inflammation.
Safety precautions with Jakura 5mg Tablet
Don’t take Jakura 5 mg if allergic to its active component, tofacitinib. Tofacitinib can weaken the immune system, increasing the risk of serious infections, including tuberculosis (TB), bacterial, fungal, or viral infections. Frequent monitoring of liver function tests is recommended if you take this medicine. It can affect blood cell counts, so routine blood tests are often necessary. Inform your doctor about your existing health condition, medicine, and supplements you may be taking to avoid drug interactions. Also, inform your doctor if you are a pregnant or breastfeeding mother.
Jakura 5mg tablet side effects
Common side effects of Jakura tofacitinib include upper respiratory infections, headache, nausea, diarrhea, high blood pressure, and increased risk of infection due to its immune-suppressing effects.
Don’t hesitate to consult a doctor if any side effects become bothersome or persist over 2-3 days.
How to use Jakura 5mg tablet
Tofacitinib is typically taken orally in tablet form, usually once or twice a day, depending on the condition and the dosage. Following your healthcare provider's instructions regarding dosage, timing, and precautions is important. The tofacitinib dosage can vary depending on the treated condition and whether you take it with other medications.
Tofacitinib can be taken with or without food. You can take it on an empty stomach, but you can take it with food if you experience stomach upset. Swallow the tablet whole with a glass of water. Do not chew, crush, or split the tablet, as this could affect how the medication is absorbed in your body. Try to take your tablet at the same time each day to help you remember. If you miss a dose, take it as soon as you remember unless it's almost time for your next dose. Do not take two doses at once to make up for a missed dose.
What is Tofacitinib and what condition does it treat?
Tofacitinib is a Janus kinase (JAK) inhibitor used to treat autoimmune conditions including rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and polyarticular course juvenile idiopathic arthritis. Marketed as Jakura 5mg among other brand names, this immunosuppressant medicine helps reduce inflammation and joint damage in patients who haven't responded adequately to other disease-modifying antirheumatic drugs. The active ingredient works by targeting specific enzymes involved in the inflammatory process, offering relief from symptoms like joint pain, swelling, and stiffness while helping to slow disease progression in chronic inflammatory conditions.
How does Tofacitinib work in the body?
Tofacitinib works by selectively blocking Janus kinase enzymes, specifically JAK1 and JAK3, which play a crucial role in transmitting inflammatory signals within immune cells. By inhibiting these pathways, Jakura 5mg reduces the production of cytokines—proteins that trigger inflammation and tissue damage in autoimmune diseases. This targeted JAK inhibitor action helps control overactive immune responses without completely suppressing the entire immune system. The mechanism differs from traditional biologics, as this oral disease-modifying therapy works inside cells rather than targeting proteins outside them, offering an alternative treatment approach for inflammatory arthritis and bowel conditions.
How long does Jakura 5mg take to work?
Jakura 5mg typically begins showing initial improvements within two to four weeks of starting treatment, though optimal results often require eight to twelve weeks of consistent use. Some patients with rheumatoid arthritis or psoriatic arthritis notice reduced joint stiffness and pain within the first month, while those taking tofacitinib for ulcerative colitis may experience symptom relief on a slightly different timeline. Response time varies based on disease severity, individual metabolism, and the specific autoimmune condition being treated. This JAK inhibitor's effectiveness builds gradually as the medication regulates inflammatory pathways, so patience during the initial treatment phase is important for achieving maximum therapeutic benefit.
When and how should I take Jakura 5mg?
Jakura 5mg should be taken orally twice daily, approximately twelve hours apart, with or without food. Swallow the tablet whole with water—do not crush, split, or chew it, as this affects the controlled-release properties of this JAK inhibitor. Consistency matters: taking tofacitinib at the same times each day maintains stable drug levels for optimal inflammation control. Your rheumatologist or gastroenterologist will prescribe the exact dosage based on your specific condition and response to treatment. Always follow your healthcare provider's instructions, as dosing may differ for rheumatoid arthritis versus ulcerative colitis, and adjustments may be needed based on lab results or concurrent medications.
Is Jakura 5mg safe for long-term use?
Jakura 5mg can be used long-term under proper medical supervision, as many patients with chronic autoimmune conditions require ongoing treatment to maintain disease control. This JAK inhibitor has been studied extensively for extended use in rheumatoid arthritis and other inflammatory diseases. However, long-term tofacitinib therapy requires regular monitoring through blood tests to check liver function, cholesterol levels, and blood cell counts. Your healthcare team will also assess infection risk and cardiovascular health periodically. While the immunosuppressant nature of this medication necessitates vigilance, many patients successfully manage their conditions with sustained use when appropriate safety protocols are followed and benefits outweigh potential risks.
Can I take Jakura 5mg with other medicines?
Jakura 5mg can interact with various medications, making it essential to inform your doctor about all drugs and supplements you're taking. This JAK inhibitor should generally not be combined with other immunosuppressants like azathioprine or biological DMARDs, as this increases infection risk. Tofacitinib levels can be affected by strong CYP3A4 inhibitors such as ketoconazole or clarithromycin, requiring dose adjustments. Some cholesterol medications, anticoagulants, and vaccines (particularly live vaccines) also require careful consideration. However, many patients safely take this antirheumatic drug alongside pain relievers, certain antacids, or cardiovascular medications with proper medical guidance and monitoring to prevent adverse drug interactions.
How does Jakura 5mg compare to similar medicines in its class?
Jakura 5mg belongs to the JAK inhibitor class alongside medications like baricitinib and upadacitinib, but tofacitinib was the first oral JAK inhibitor approved for rheumatoid arthritis. Compared to other disease-modifying antirheumatic drugs, this immunosuppressant offers the convenience of tablet form versus injectable biologics like TNF inhibitors. Different JAK inhibitors show varying selectivity for enzyme subtypes—tofacitinib primarily targets JAK1 and JAK3, while others focus on different combinations. Clinical efficacy is generally comparable across the class for inflammatory arthritis, though individual patient response varies. The choice between JAK inhibitors often depends on specific condition, side effect profile, dosing convenience, and cost considerations.
Is the generic Tofacitinib as effective as branded versions?
Generic tofacitinib contains the identical active pharmaceutical ingredient as branded versions like Jakura 5mg and delivers equivalent therapeutic effectiveness for treating rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. Regulatory authorities including the FDA, EMA, and TGA require generic JAK inhibitors to demonstrate bioequivalence—meaning they're absorbed and work in the body at the same rate and extent as original formulations. The same immunosuppressant action and disease-modifying benefits apply whether you choose generic or branded antirheumatic medication. Quality standards are equally rigorous. The primary difference lies in price and manufacturer, making generics a cost-effective alternative without sacrificing clinical outcomes for inflammatory condition management.
Why do patients choose PremiumRxDrugs for Jakura 5mg?
Patients select PremiumRxDrugs for their tofacitinib prescriptions due to several compelling advantages: competitive pricing on this JAK inhibitor makes long-term treatment more affordable, while guaranteed authenticity ensures you receive genuine Jakura 5mg directly from manufacturers. The pharmacy's discreet packaging respects privacy, and flexible shipping options including free delivery to the USA, UK, Australia, and Canada reduce overall costs. Our easy prescription management and reorder system simplifies ongoing therapy for chronic conditions like rheumatoid arthritis. With over ten years serving the international community, we combine pharmaceutical expertise, customer service excellence, and reliable access to both branded and generic immunosuppressant medications.
What are the common side effects of Tofacitinib?
Common side effects of tofacitinib include upper respiratory tract infections, headaches, diarrhea, and nasal congestion. Some patients taking this JAK inhibitor experience mild increases in cholesterol levels or minor changes in liver enzyme readings detected through routine blood work. Nausea and stomach discomfort can occur, particularly when starting treatment. As an immunosuppressant, tofacitinib may increase susceptibility to infections ranging from colds to more serious bacterial or viral illnesses. Other frequently reported effects include fatigue, cough, and elevated blood pressure. While most side effects are manageable and decrease over time, monitoring through regular medical check-ups helps identify any concerning changes early in your antirheumatic therapy.
Who should avoid taking Tofacitinib?
Tofacitinib should be avoided by individuals with active serious infections, as this immunosuppressant can reduce the body's ability to fight pathogens. People with severe liver disease, low blood cell counts, or those at high cardiovascular risk may not be suitable candidates for this JAK inhibitor. Pregnant or breastfeeding women should not use tofacitinib due to potential risks to the developing baby. Patients with a history of blood clots, certain cancers, or gastrointestinal perforation require careful evaluation before starting this antirheumatic therapy. Those who've had inadequate response to tuberculosis treatment or have latent TB need additional screening. Your rheumatologist or gastroenterologist will assess your complete medical history before prescribing this medication.
Login
Sign Up
Login
Sign Up